image: Ali Hajiluyi via Unsplash
Transgender and gender non-conforming people have higher risk of cardiovascular disease than the general population. This is due to a variety of factors including discrimination, minority stress, medical mistreatment, poverty, higher rates of comorbidities like HIV and tobacco dependence, and lack of access to routine, high-quality healthcare.
And, to some degree, it seems, gender-affirming hormone therapy (specifically with testosterone). Two recent publications (here and here) agree that lipid profiles are adversely affected in transgender men taking testosterone, and by extension, calculated cardiovascular risk is also affected. As more evidence accumulates, risk relationships are coming into clearer focus. And risk, it seems, is real.
But don’t let this deter you: gender-affirming healthcare saves lives. Suicide is a major risk for transgender people. This is on top of the risks associated with lack of access to routine care. Providing safe access to gender-affirming care, including hormone therapy if desired, is a powerful tool that reduces suicide and improves quality of life. And the medical community knows how to mitigate the risk of cardiovascular disease.
The transgender and gender-nonconforming population is diverse (and for that reason, I’ll use the term “gender diverse” from here). Some people might use pronouns you’re not familiar with. Some might identify as non-binary or another category you’re not familiar with. Some might be children. Some might be old. They can and do have every comorbidity you can think of, just like everyone else. Of course, this includes the number one killer of US adults: cardiovascular disease. And it’s not always entirely clear what the risk is, given the paucity of evidence about this population (there’s no gender identity data in the Framingham Heart Study, is there?).
Whether testosterone is prescribed or not, clinicians who care for gender diverse patients need to integrate risk reduction into gender-affirming care in meaningful and robust ways. The conversation cannot stop at “let’s measure lipid levels at baseline and check in every once in a while”. It cannot stop at “we offered tobacco cessation counseling”. It cannot stop at “we discussed the risks and benefits”. We can do more.
This is a health equity issue. Medical providers, are you doing your part?
We’ll continue to see more evidence about the health of gender-diverse people over the coming years. More research is underway, and research protocols are slowly becoming more nuanced and inclusive. As the evidence matures, we’ll likely see more risk factors emerge. We are responsible for taking this evidence into context and using it to reduce risk — not to create barriers to care.
I spent many summers on Long Island when it was still a forest wonderland of…
There’s a line I’ve always loved: “The map is not the territory.” Alfred Korzybski wrote…
Every industry has its signature gatherings, places where thought leaders assemble to shape the next…
The Raines discovered their son Adam in the closet where he hung himself with the…
On a damp, equatorial morning in Belém, the river smells faintly of diesel and guava. Vendors…
[Reprinted with permission from KFF Health News. Authored by Céline Gounder] Department of Health and…
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More